"10.1371_journal.pone.0080579","plos one","2013-12-12T00:00:00Z","Truc Hoang; Claus Aagaard; Jes Dietrich; Joseph P Cassidy; Gregory Dolganov; Gary K Schoolnik; Carina Vingsbo Lundberg; Else Marie Agger; Peter Andersen","TB Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark; Adjuvant Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark; Veterinary Sciences Centre, School of Agriculture, Food Science and Veterinary Medicine, University College Dublin, Belfield, Dublin, Ireland; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, United States of America; Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark","Conceived and designed the experiments: TH PA. Performed the experiments: TH CA JD JPC GKS GD CVL. Analyzed the data: TH CA JD JPC GKS GD EA. Contributed reagents/materials/analysis tools: TH CA JD JPC GKS GD EA. Wrote the manuscript: TH EA PA.","Some of the initial studies on H4/H28 were partially supported Sanofi Aventis but the company had no influence on study design, data collection, data analysis or preparation of the manuscript.
We also declare that Truc Hoang, Peter Andersen, Jes Dietrich and Carina Vingsbo Lundberg are co-inventors on the patent WO2010121618 â€œA tuberculosis TB vaccine to prevent reactivation.\" All rights have been assigned to Statens Serum Institut, a Danish not-for-profit governmental institute. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Truc Hoang","TH",9,TRUE,2,7,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
